We are live on ! Find out more
ISL

Ingalls & Snyder LLC Portfolio holdings

AUM $2.83B
1-Year Est. Return 21.61%
This Fund
S&P 500
This Quarter Est. Return
+5.67%
1 Year Est. Return
+21.61%
3 Year Est. Return
+166.27%
5 Year Est. Return
+212.01%
10 Year Est. Return
+695.23%
AUM
$1.95B
AUM Growth
+$108M
Cap. Flow
+$36.7M
Cap. Flow %
1.88%
Top 10 Hldgs %
38.39%
Holding
457
New
17
Increased
108
Reduced
186
Closed
24

Top Buys

Rank Stock Value
1
CORT icon
Corcept Therapeutics
CORT
+$33.9M
2
CNQ icon
Canadian Natural Resources
CNQ
+$5.27M
3
PXD
Pioneer Natural Resource Co.
PXD
+$4.97M
4
PAAS icon
Pan American Silver
PAAS
+$3.54M
5
OMER icon
Omeros
OMER
+$3.53M

Top Sells

Rank Stock Value
1
CNCE
Concert Pharmaceuticals, Inc.
CNCE
+$7.57M
2
INTC icon
Intel
INTC
+$951K
3
HXL icon
Hexcel
HXL
+$791K
4
NVEI
Nuvei Corporation Subordinate Voting Shares
NVEI
+$777K
5
MSFT icon
Microsoft
MSFT
+$687K

Sector Composition

Rank Sector Weight
1 Healthcare 21.25%
2 Energy 17.15%
3 Technology 13.62%
4 Financials 12.38%
5 Industrials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CORT icon
1
Corcept Therapeutics
CORT
$9.72B
$181M 9.31%
8,370,017
+1,544,755
+23% +$33.9M
PXD
2
DELISTED
Pioneer Natural Resource Co.
PXD
$106M 5.46%
520,668
+23,108
+5% +$4.97M
CNQ icon
3
Canadian Natural Resources
CNQ
$91.5B
$89.9M 4.62%
3,250,188
+185,898
+6% +$5.27M
AAPL icon
4
Apple
AAPL
$4.9T
$78.5M 4.03%
476,187
-35
-0% -$5.16K
MSFT icon
5
Microsoft
MSFT
$2.93T
$69M 3.55%
239,495
-2,694
-1% -$687K
BRK.B icon
6
Berkshire Hathaway Class B
BRK.B
$1.06T
$64.2M 3.3%
207,919
-812
-0.4% -$250K
WMB icon
7
Williams Companies
WMB
$89.7B
$52.7M 2.71%
1,766,125
+9,739
+0.6% +$301K
PG icon
8
Procter & Gamble
PG
$349B
$36.5M 1.87%
245,219
-1,988
-0.8% -$284K
GOOGL icon
9
Alphabet (Google) Class A
GOOGL
$4.23T
$35.6M 1.83%
343,033
-1,827
-0.5% -$175K
BMY icon
10
Bristol-Myers Squibb
BMY
$124B
$33.2M 1.7%
478,653
+17,032
+4% +$1.2M
JPM icon
11
JPMorgan Chase
JPM
$907B
$31.7M 1.63%
243,319
+350
+0.1% +$48K
HXL icon
12
Hexcel
HXL
$7.83B
$30.5M 1.57%
446,389
-11,653
-3% -$791K
MRK icon
13
Merck
MRK
$315B
$29.7M 1.53%
279,480
-1,461
-0.5% -$158K
ABBV icon
14
AbbVie
ABBV
$450B
$26.8M 1.38%
168,386
-38
-0% -$5.81K
ROP icon
15
Roper Technologies
ROP
$36.6B
$25.8M 1.33%
58,589
-834
-1% -$360K
RRC icon
16
Range Resources
RRC
$8.66B
$25M 1.28%
942,800
+34,650
+4% +$872K
PFE icon
17
Pfizer
PFE
$143B
$24.4M 1.25%
597,932
+16,737
+3% +$723K
DE icon
18
Deere & Co
DE
$161B
$24.1M 1.24%
58,391
-186
-0.3% -$77K
TECK icon
19
Teck Resources
TECK
$27B
$22.4M 1.15%
613,110
+32,650
+6% +$1.3M
OMER icon
20
Omeros
OMER
$701M
$21.7M 1.11%
4,663,541
+976,800
+26% +$3.53M
HD icon
21
Home Depot
HD
$338B
$21.1M 1.08%
71,540
+35
+0% +$10.7K
UL icon
22
Unilever
UL
$134B
$20.9M 1.07%
357,769
+17,303
+5% +$983K
STRS icon
23
Stratus Properties
STRS
$165M
$20.8M 1.07%
1,041,757
+130,000
+14% +$2.7M
GOOG icon
24
Alphabet (Google) Class C
GOOG
$4.22T
$20.8M 1.07%
200,076
-1,337
-0.7% -$129K
RTX icon
25
RTX Corp
RTX
$261B
$18.4M 0.95%
187,904
-2,103
-1% -$207K
1
2 3 4 5

Similar funds

GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
SL
Summitry LLC Foster City, California $2.83B AUM 17.32% 1-Year Est. Return
AF
Aviso Financial Toronto, Ontario, Canada $2.82B AUM 24.96% 1-Year Est. Return
SIC
Schwartz Investment Counsel Plymouth, Michigan $2.82B AUM 13.66% 1-Year Est. Return
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $2.84B AUM 30.75% 1-Year Est. Return
AIP
Atlas Infrastructure Partners London, United Kingdom $2.84B AUM 4.75% 1-Year Est. Return
SAI
Systematic Alpha Investments Princeton, New Jersey $2.84B AUM 27.03% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $2.85B AUM

Ingalls & Snyder LLC's Q1 2023 Portfolio in Review

As of Q1 2023, Ingalls & Snyder LLC held 457 positions worth $1.95B, up 5.9% from $1.84B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Ingalls & Snyder LLC's Q1 2023 filing shows 17 new, 108 increased, 186 reduced and 24 closed positions. Its largest new stake was TSMC: 31,331 shares worth $2.91M. The largest sale was Concert Pharmaceuticals, Inc., an estimated $7.57M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Energy and Technology.

  • Ingalls & Snyder LLC's largest Q1 2023 buy was TSMC: 31,331 shares worth $2.91M.
  • Ingalls & Snyder LLC added most to Corcept Therapeutics in Q1 2023, an estimated $33.9M increase.
  • Ingalls & Snyder LLC's biggest Q1 2023 reduction was Intel, cutting an estimated $951K.
  • Ingalls & Snyder LLC fully exited Concert Pharmaceuticals, Inc. in Q1 2023, selling an estimated $7.57M.
  • Ingalls & Snyder LLC's ten largest holdings make up 38% of its $1.95B portfolio in Q1 2023.
  • Ingalls & Snyder LLC opened 17 new positions and closed 24 in Q1 2023.
  • Ingalls & Snyder LLC's portfolio value rose 5.9% quarter-over-quarter to $1.95B.

Based on Ingalls & Snyder LLC's 13F filing for Q1 2023, filed 9 May 2023.